Mice treated with Pcpa exhibited MUC2 expression similar to the control group and increased PCNA expression, indicating that inhibiting 5-HT synthesis could mitigate CRS-induced intestinal changes. This evidence concerns the gene MUC2 and congenital rubella syndrome.